Zymeworks Inc.

Canada


 
Quantité totale PI 256
Rang # Quantité totale PI 5 126
Note d'activité PI 3/5.0    157
Rang # Activité PI 4 367
Symbole boursier ZYME (nyse)
ISIN CA98985W1023
Capitalisation 1,900M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

98 11
62 0
85 0
0
 
Dernier brevet 2025 - Antibody drug-conjugates targeti...
Premier brevet 2006 - System and method for modeling i...
Dernière marque 2024 - ZYMEWORKS
Première marque 2009 - ZYMEWORKS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Antibody drug-conjugates targeting c-met and methods of use thereof. Antibody-drug conjugates (A...
Invention Immunomodulator purine-derived compounds, conjugates thereof, and methods of use thereof. Purine...
Invention Modified antigen bindingpolypeptide constructs and uses thereof. The present invention provides ...
2024 Invention Bispecific antigen binding constructs targeting her2. Provided herein are biparatopic antigen-bi...
Invention Methods of using bispecific antigen-binding constructs targeting her2. Described herein methods ...
Invention Anti-napi2b antibody-drug conjugates and methods of use. Described herein are anti-NaPi2b antibod...
P/S Pharmaceutical preparations; medicines for human purposes; diagnostic preparations for medical pu...
Invention Stable heterodimeric antibody design with mutations in the fc domain. The provided scaffolds hav...
Invention Immunomodulatory trispecific t cell engager fusion proteins. The present disclosure provides fus...
Invention Methods of using a bispecific antigen-binding construct targeting her2 in combination with cdk4/6...
Invention Multivalent and bispecific antibody constructs and methods of use thereof. The present disclosure...
Invention Antibody-drug conjugates targeting folate receptor alpha and methods of use. Antibody-drug conju...
Invention Bis-intercalating peptides, conjugates and methods of use. Bis-intercalating peptide compounds h...
Invention Modified interleukin p40 subunit proteins and methods of use thereof. This disclosure generally ...
Invention Bispecific asymmetric heterodimers comprising anti-cd3 constructs. Disclosed herein are isolated...
Invention Multivalent polypeptide constructs capable of binding viral spike proteins and methods of using t...
Invention Fc variant with high thermal stability and attenuated effector function. A polypeptide comprisin...
P/S Scientific research and development of preparations, agents and technology for the development of...
2023 Invention Anti-napi2b antibodies and methods of use
Invention Antibody-drug conjugates targeting napi2b and methods of use
Invention Trivalent and trispecific antibody constructs and methods of use thereof
Invention Anti-napi2b antibodies and methods of use. Described herein are antibody constructs that bind hum...
Invention Antibody-drug conjugates targeting napi2b and methods of use. Described herein are antibody-drug ...
Invention Trivalent and trispecific antibody constructs and methods of use thereof. The present disclosure ...
Invention Antibody-drug conjugates targeting glypican-3 and methods of use. Described herein are antibody-d...
Invention Antibody-drug conjugates targeting glypican-3 and methods of use
Invention Antibody drug conjugates targeting c-met and methods of use
Invention Antibody drug conjugates targeting c-met and methods of use. Antibody-drug conjugates (ADCs) comp...
P/S Chemical, biochemical and biological research and analysis; biotechnological research and develop...
Invention Multivalent and bispecific antibody constructs and methods of use thereof
Invention Immunomodulator purine-derived compounds, conjugates thereof, and methods of use thereof. Disclos...
Invention Immunomodulatory compounds, conjugates thereof, and methods of use thereof
Invention Antibody-drug conjugates targeting folate receptor alpha and methods of use. Antibody-drug conjug...
Invention Anti-folate receptor alpha antibodies and methods of use
Invention Anti-folate receptor alpha antibodies and methods of use. Antibody constructs that bind human fol...
Invention Cytotoxic and anti-mitotic compounds, and methods of using the same. Compounds having cytotoxic a...
Invention Methods of using anti-her2 biparatopic antibody-drug conjugates in the treatment of cancer. Metho...
Invention Immunomodulatory trispecific t cell engager fusion proteins. The present disclosure provides fusi...
2022 Invention Sulfonamide-containing linkage systems for drug conjugates. Sulfonamide-containing linkage syste...
Invention Systems and methods for polymer side-chain conformation prediction. Disclosed systems and method...
Invention Systems and methods for polymer sequence prediction. Systems and methods for polymer sequence pr...
Invention Methods of treating cancer with anti-her2 biparatopic antibodies. Methods of treating subjects h...
P/S Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in o...
Invention Camptothecin analogues, conjugates and methods of use. Camptothecin analogues of Formula (I) and...
2021 Invention Stabilized tcr constructs and methods of use. Stabilized TCR constructs comprising a TCR alpha c...
Invention Imidazothienopyridine compounds and methods of use. Disclosed herein are compounds having Formul...
Invention Heterodimeric iga fc constructs and methods of use thereof. Heterodimeric IgA Fc (IgA HetFc) con...
Invention Fusion proteins comprising a ligand-receptor pair and a biologically functional protein. The pre...
Invention Heterodimeric fc variants selective for fc gamma riib. Heterodimeric Fc variants comprising one ...
Invention Immunoglobulin fc region variants comprising stability-enhancing mutations. Fc variants are desc...
Invention Antibody constructs binding 4-1bb and folate receptor alpha and uses thereof. Described herein a...
2019 P/S Chemical molecular analysis and product optimization provided to pharmaceutical, biotechnology an...
2016 P/S Chemical preparations for use in the manufacture of pharmaceuticals
2013 P/S Therapeutic, prophylactic preparations, and pharmaceutical preparations and agents for the treatm...
2009 P/S Chemical molecular analysis and product optimization, namely, product research and development fo...